gonadotropic


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to gonadotropic: gonadotropic hormones

go·nad·o·trop·ic

 (gō-năd′ə-trŏp′ĭk, -trō′pĭk) also go·nad·o·troph·ic (-trŏf′ĭk, -trō′fĭk)
adj.
Acting on or stimulating the gonads: a gonadotropic hormone.

go•nad•o•trop•ic

(goʊˌnæd əˈtrɒp ɪk, -ˈtroʊ pɪk)

adj.
affecting the development or activity of the ovary or testis.
[1930–35]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.gonadotropic - of or relating to or involving gonadotropin
References in periodicals archive ?
2004), and BPF also had uterotropic (estrogenic) effects in female rodents and gonadotropic (androgenic) effects in male rodents (Higashihara et al.
As one of the most important gonadotropic hormones in adult insects, 20E plays a critical role in the immediate control of oogenesis (Bownes 1989).
after 13 days post-infection and vertical transmission could be detected in the 2nd gonadotropic cycle (33).
Steroidogenesis in ovary is regulated by pituitary gonadotropic hormones follicle-stimulating hormone (FSH) and luteinizing hormone (LH) through their respective receptors located on ovarian follicles (Camp et al.
MENOPUR is a potent gonadotropic substance capable of causing Ovarian Hyperstimulation Syndrome (OHSS), with or without pulmonary or vascular complications, in women undergoing therapy for infertility.
Although others had described a gonadotropic substance present in the placenta, it was Aschheim and Zondek who discovered hCG in the urine in their demonstration of ovarian stimulation of immature female mice injected with the urine of pregnant women (2, 3).
is a potent gonadotropic substance capable of causing mild to severe adverse reactions, including: Ovarian Hyperstimulation Syndrome (OHSS) in women with or without pulmonary or vascular complications, and multiple births.
inhibin) and Leydig cells, exerts a negative feedback control on the production of gonadotropic hormones (FSH and LH).
Microscopic examination of pituitary adenoma specimens shows many gonadotropin cells with small secretory granules and, immunohistochemical examination shows pituitary gonadotropic hormone antibody positivity.
After the maturation pathway of either gender phase has been initiated, gametogenesis as such is not affected, making feminizing estrogenic gonadotropic interference unlikely to be a significant contributor to the lack of females.
In 1958, commenting on the use of androgens Kistner (26) noted that "androgenic substances, while adequately documented as having produced desirable results in endometriosis, probably exert their effect through inhibition of gonadotropic substances, although direct effect of the substance upon the endometriotic area has been suggested".